MATERNAL SERUM INTERLEUKIN 6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
基本信息
- 批准号:6274019
- 负责人:
- 金额:$ 2.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-12-01 至 1998-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Background: Preterm premature rupture of membranes (PROM) continues to be
a leading cause of neonatal morbidity and mortality. Preterm PROM occurs
in approximately 2% of all pregnancies but is associated with 20% of all
perinatal deaths. By far, the most common complication of preterm PROM is
related to intra-amniotic infection termed chorioamnionitis.
Chorioamnionitis occurs in 6% of preterm deliveries without PROM but is
present in at least 27% of preterm deliveries with PROM; it is associated
with a fourfold increase in neonatal mortality. Clinical signs of
infection are subtle and usually not present in early chorioamnionitis.
Currently there are no reliable clinical markers to adequately indicate
impending intrauterine infection in these patients.
The cytokine interleukin(IL)-6, thought to have an important role in the
intrauterine response to infection, has been reported to be elevated in
the amniotic fluid of patients with preterm PROM with intra-amniotic
infection. Unfortunately, the widespread clinical use of amniotic fluid
IL-6 concentrations in the management of preterm PROM patients would be
limited due to the technical difficulty of amniocentesis. Recent studies
in our laboratory demonstrate a significant rise in serum IL-6
concentrations in patients with preterm PROM and clinical or histologic
evidence of infection on the day of delivery.
背景:早产胎膜早破(PROM)仍然是
是新生儿发病率和死亡率的主要原因。 早产PROM发生
大约2%的怀孕,但与20%的
围产期死亡 到目前为止,早产胎膜早破最常见的并发症是
与羊膜内感染绒毛膜炎有关
绒毛膜炎发生在6%的早产无胎膜早破,
至少有27%的胎膜早破早产;它与
新生儿死亡率增加了四倍 的临床体征
感染是轻微且通常不存在于早期绒毛膜炎中。
目前没有可靠的临床标志物来充分指示
这些患者的子宫内感染。
细胞因子白细胞介素(IL)-6,被认为具有重要的作用,
子宫内对感染的反应,据报道在
羊水内注射治疗早产胎膜早破
感染不幸的是,羊水的广泛临床应用
IL-6浓度在早产胎膜早破患者的管理将是
由于穿刺术的技术难度而受到限制。 最近的研究
在我们实验室中证实血清IL-6显著升高
早产胎膜早破患者和临床或组织学
分娩当天有感染的迹象。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AMY P. MURTHA其他文献
AMY P. MURTHA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AMY P. MURTHA', 18)}}的其他基金
MATERNAL SERUM INTERLEUKIN-6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
- 批准号:
7198448 - 财政年份:2005
- 资助金额:
$ 2.88万 - 项目类别:
Maternal Serum IL6 in Preterm Premature Rupture of Mem.
早产儿子宫肌层过早破裂的母体血清 IL6。
- 批准号:
6974007 - 财政年份:2004
- 资助金额:
$ 2.88万 - 项目类别:
MATERNAL SERUM INTERLEUKIN 6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
- 批准号:
6565361 - 财政年份:2001
- 资助金额:
$ 2.88万 - 项目类别:
MATERNAL SERUM INTERLEUKIN 6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
- 批准号:
6415302 - 财政年份:2000
- 资助金额:
$ 2.88万 - 项目类别:
MATERNAL SERUM INTERLEUKIN 6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
- 批准号:
6463064 - 财政年份:2000
- 资助金额:
$ 2.88万 - 项目类别:
MATERNAL SERUM INTERLEUKIN 6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
- 批准号:
6503101 - 财政年份:2000
- 资助金额:
$ 2.88万 - 项目类别:
MATERNAL SERUM INTERLEUKIN 6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
- 批准号:
6112785 - 财政年份:1998
- 资助金额:
$ 2.88万 - 项目类别:
EVALUATION OF CORTICOSTEROIDS IN REFRACTORY HYPEREMESIS
难治性剧吐中皮质类固醇的评估
- 批准号:
6274007 - 财政年份:1997
- 资助金额:
$ 2.88万 - 项目类别:
EVALUATION OF CORTICOSTEROIDS IN REFRACTORY HYPEREMESIS
难治性剧吐中皮质类固醇的评估
- 批准号:
6112773 - 财政年份:
- 资助金额:
$ 2.88万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 2.88万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:














{{item.name}}会员




